| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 167.912 | 167.037 | 154.205 | 125.175 | 98.585 | 100.326 | 110.527 | 136.943 | 123.498 | 93.919 |
| Total Income - EUR | 168.731 | 170.069 | 154.980 | 129.498 | 98.686 | 110.137 | 112.628 | 141.207 | 128.812 | 292.617 |
| Total Expenses - EUR | 154.825 | 169.131 | 143.242 | 144.808 | 120.361 | 102.769 | 106.761 | 104.100 | 123.338 | 125.910 |
| Gross Profit/Loss - EUR | 13.906 | 938 | 11.738 | -15.310 | -21.676 | 7.368 | 5.867 | 37.107 | 5.474 | 166.707 |
| Net Profit/Loss - EUR | 11.450 | 203 | 443 | -16.606 | -22.662 | 6.549 | 4.924 | 35.724 | 4.214 | 158.991 |
| Employees | 17 | 17 | 16 | 15 | 14 | 12 | 12 | 10 | 10 | 4 |
Check the financial reports for the company - Valpet Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 154.784 | 169.818 | 140.657 | 123.451 | 87.367 | 74.671 | 63.257 | 60.148 | 383.623 | 345.083 |
| Current Assets | 53.683 | 22.403 | 36.782 | 23.259 | 18.709 | 28.058 | 44.430 | 74.579 | 1.400 | 40.730 |
| Inventories | 9.038 | 568 | 2.359 | 408 | 316 | 0 | 1.029 | 660 | 0 | 2.279 |
| Receivables | 44.365 | 18.957 | 34.369 | 22.564 | 18.377 | 27.785 | 43.367 | 73.925 | 126 | 1.106 |
| Cash | 280 | 2.878 | 54 | 288 | 16 | 273 | 34 | -6 | 1.274 | 37.345 |
| Shareholders Funds | 38.747 | 8.569 | 8.867 | -7.902 | -30.411 | -23.285 | -17.845 | 13.188 | 17.362 | 176.257 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 173.722 | 190.573 | 171.634 | 158.852 | 148.312 | 129.612 | 126.560 | 121.944 | 367.661 | 209.556 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Valpet Med Srl